Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Dollar and Under Sleeper Stocks -- Ignore unavailable to you. Want to Upgrade?

To: Ga Bard who wrote (3542)	12/22/1997 10:30:00 AM
From: mtnres	Respond to of 8835

Aqua Vie Beverage Corporation Announces Proposed Agreement with Lyons Magnus Bottling Business Wire - December 22, 1997 09:27 KETCHUM, Idaho--(BUSINESS WIRE)--Dec. 22, 1997--Aqua Vie Beverage Corporation (OTC:AVBC), announced today that Aqua Vie Beverage Corporation and Lyons Magnus have reached an agreement in principle, whereby Lyons will produce Aqua Vie's Hydrator(TM) product line for Aqua Vie's west coast distribution, starting in January 1998. Lyons Magnus is one of California's largest manufacturers of beverages and fruit products, and operates a state-of-the-art manufacturing facility where it currently bottles for beverage companies and distributors in the U.S. and Asia. Under the proposed terms of the agreement, Lyons Magnus will begin production of Aqua Vie's Hydrator(TM) product line on January 26th. Lyons has experience producing Aqua Vie products and was the bottling facility that originally successfully tested the production of Aqua Vie's new "all natural" products, through their proprietary aseptic bottling process. The agreement is subject to completion of due diligence, and definitive documentation, which is expected to be completed within approximately two weeks. Tom Gillespie, founder of Aqua Vie said that this alliance takes place during a time when the bottled water business is today, the fastest growing segment in the $6 billion alternative beverage industry. However, Aqua Vie's entire portfolio of natural waters, non-carbonated hydrational beverages, functional beverages, and non-alcoholic wine beverages bridges the full spectrum of the over $100 billion world wide beverage marketplace. "This agreement represents a milestone for those who helped build Aqua Vie, those who helped rescue it, and all who can now look forward to enjoying these unique beverages," said Gillespie. "It also marks the beginning of Aqua Vie's west coast operations, and for the company, puts some closure on the past. The Lyons Magnus facility maintains industry-leading production standards, and is well acquainted with our products. It is the ideal manufacturing facility to facilitate the introduction of Aqua Vie's 'all natural' products to the West Coast." Robert Smittcamp, CEO of Lyons Magnus said, "We've watched the struggle to bring Aqua Vie to the marketplace over the past three years, and look forward to completing this project, that we originally started with Tom." For further information on Aqua Vie Beverage Corporation, visit our web site at: aquavie.com . Note to editors: Statements in this news release that are not historical are to be regarded as forward-looking statements which are subject to risks and uncertainties that could cause actual results to differ materially. CONTACT: Aqua Vie Corp. Jim Parker, 208/725-0807

To: Ga Bard who wrote (3542)	12/22/1997 2:04:00 PM
From: Bo Didley	Read Replies (2) \| Respond to of 8835

Auxer (otc/bb: AXGI) market-pulse.com Ga Bard, I see you follow this company. End of year tax selling has taken it down to an ask of .29 Auxer officials have confirmed that they will make two positive announcements in January that will account for major revenue increases for 1998. What is your opinion on this stock at current levels? Is it undervalued? Will it move well when the news is released? Are the fundamentals of the company very sound? Could I realistically concieve of a 100% return in a month? Here is a place that follows Auxer: market-pulse.com Thanks, Bo

To: Ga Bard who wrote (3542)	12/22/1997 7:43:00 PM
From: Bob B.	Read Replies (2) \| Respond to of 8835

I was wandering if any one had any thoughts on APPI. Looks to be at the bottom of a long slide. They have just signed distribution agreements for their low cholesterol drug in Europe and in the U.s. And they have several products awaiting FDA aproval including an AIDS drug. It's at around .07 now. Thanks in advance Bob Braund